QUIDEL CORP /DE/
S-3, EX-23.2, 2000-08-21
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: QUIDEL CORP /DE/, S-3, EX-5.1, 2000-08-21
Next: QUIDEL CORP /DE/, S-3, EX-23.3, 2000-08-21



<PAGE>




                                  EXHIBIT 23.2

CONSENT OF INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) of Quidel Corporation for the registration of
950,000 shares of its common stock and to the incorporation by reference therein
of our report dated May 14, 1999, with respect to the consolidated financial
statements of Quidel Corporation as of March 31, 1999 included in its Annual
Report (Form 10-K) for the period April 1, 1999 to December 31, 1999, filed with
the Securities and Exchange Commission.



                                                       /s/ Ernst & Young LLP
                                                       -----------------------
                                                       Ernst & Young LLP




San Diego, California
August 18, 2000











© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission